Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 46 of 202 for:    TETRACYCLINE

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02483715
Recruitment Status : Completed
First Posted : June 29, 2015
Last Update Posted : March 26, 2019
Information provided by (Responsible Party):
National Taiwan University Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2018
Actual Study Completion Date : May 2018